TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts6677
Avg. Estimate-0.21-0.17-0.62-0.34
Low Estimate-0.31-0.19-0.68-0.52
High Estimate-0.15-0.14-0.58-0.08
Year Ago EPS-0.07-0.1-0.37-0.62
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts6677
Avg. Estimate4.42M6.43M18.67M116.78M
Low Estimate4M5.02M16.75M74M
High Estimate5.09M8.5M20.7M180.2M
Year Ago Sales4.42M4.12M16.78M18.67M
Sales Growth (year/est)0.00%55.90%11.30%525.50%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-0.11-0.09-0.1-0.12
EPS Actual-0.07-0.1-0.11-0.15
Difference0.04-0.01-0.01-0.03
Surprise %36.40%-11.10%-10.00%-25.00%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.21-0.17-0.62-0.34
7 Days Ago-0.19-0.16-0.62-0.34
30 Days Ago-0.2-0.16-0.63-0.35
60 Days Ago-0.13-0.14-0.52-0.16
90 Days Ago-0.13-0.14-0.52-0.17
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1222
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesTXMDIndustrySectorS&P 500
Current Qtr.-200.00%N/AN/A0.32
Next Qtr.-70.00%N/AN/A0.43
Current Year-67.60%N/AN/A0.24
Next Year45.20%N/AN/A0.27
Next 5 Years (per annum)15.00%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A